MCS, B., CL, B., W, C., LE, C., J, G., C, H., . . . G, J. (2022). Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: A consensus statement. European journal of endocrinology, 186(6), P35. https://doi.org/10.1530/EJE-21-1186
Chicago Style (17th ed.) CitationMCS, Boguszewski, et al. "Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement." European Journal of Endocrinology 186, no. 6 (2022): P35. https://doi.org/10.1530/EJE-21-1186.
MLA (9th ed.) CitationMCS, Boguszewski, et al. "Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement." European Journal of Endocrinology, vol. 186, no. 6, 2022, p. P35, https://doi.org/10.1530/EJE-21-1186.